Lucid Diagnostics Ownership | Who Owns Lucid Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Lucid Diagnostics Ownership Summary


Lucid Diagnostics is owned by 6.41% institutional investors, 60.83% insiders, and 32.76% retail investors. Luminus management is the largest institutional shareholder, holding 2.02% of LUCD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.88% of its assets in Lucid Diagnostics shares.

LUCD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLucid Diagnostics6.41%60.83%32.76%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryMedical Device Stocks40.18%9.93%49.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Luminus management1.02M2.02%$832.39K
Vanguard group560.91K1.11%$459.39K
Sargent investment group541.50K1.07%$442.41K
Geode capital management279.50K0.55%$228.85K
Lido advisors140.02K0.28%$114.63K
Nantahala capital management94.54K0.19%$77.40K
Goldman sachs group63.58K0.13%$52.05K
Hrt financial lp59.64K0.12%$48.00K
Lpl financial53.39K0.11%$43.71K
Blackrock27.31K0.06%$22.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Luminus management1.02M0.96%$832.39K
Sargent investment group541.50K0.07%$442.41K
Byrne asset management11.00K0.01%$9.56K
Nantahala capital management94.54K0.00%$77.40K
Two sigma securities19.32K0.00%$15.81K
Xtx topco25.32K0.00%$20.73K
Gotham asset management10.44K0.00%$104.53K
Americana partners26.43K0.00%$21.64K
Virtu financial14.16K0.00%$12.00K
Geneos wealth management29.55K0.00%$24.23K

Top Buyers

HolderShares% AssetsChange
Sargent investment group541.50K0.07%541.50K
Geode capital management279.50K-65.96K
Goldman sachs group63.58K-63.58K
Hrt financial lp59.64K0.00%59.64K
Lido advisors140.02K0.00%40.00K

Top Sellers

HolderShares% AssetsChange
Luminus management1.02M0.96%-136.19K
Levin capital strategies---66.53K
Verition fund management---39.71K
Nantahala capital management94.54K0.00%-31.82K
Citadel advisors---29.30K

New Positions

HolderShares% AssetsChangeValue
Sargent investment group541.50K0.07%541.50K$442.41K
Goldman sachs group63.58K-63.58K$52.05K
Hrt financial lp59.64K0.00%59.64K$48.00K
Americana partners26.43K0.00%26.43K$21.64K
Xtx topco25.32K0.00%25.32K$20.73K

Sold Out

HolderChange
Thompson investment management-1.00
Ubs group-2.00
Newedge advisors-2.00
Newbridge financial services group-50.00
Qube research-103.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243114.81%3,227,77831.56%627.01%1880.00%814.29%
Sep 30, 202427-15.63%2,453,40423.06%424.83%10-33.33%7-22.22%
Jun 30, 20243214.29%1,993,585-3.75%418.00%15-25.00%950.00%
Mar 31, 20242816.67%2,071,20418.45%428.43%20150.00%6-25.00%
Dec 31, 2023244.35%1,748,600-8.70%419.93%8-27.27%860.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv612.60K0.88%245.68K
Vanguard Institutional Extnd Mkt Idx Tr193.99K0.28%-
Fidelity Extended Market Index137.65K0.15%-877.00
Fidelity Total Market Index56.41K0.06%-
Fidelity Nasdaq Composite Index38.29K0.04%-
NT Ext Equity Mkt Idx Fd - L26.20K0.04%14.93K
Spartan Total Market Index Pool G21.61K0.03%17.73K
Fidelity Series Total Market Index25.15K0.03%1.16K
Spartan Extended Market Index Pool F19.21K0.03%877.00
Spartan Total Market Index Pool E21.61K0.02%17.73K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 25, 2023Lapidus Stanley-Sell$286.00
Sep 26, 2023Lapidus Stanley-Sell$14.30K
Sep 26, 2023Lapidus Stanley-Sell$14.13K
Sep 26, 2023Lapidus Stanley-Sell$14.74K
Sep 20, 2023Lapidus Stanley-Sell$4.94K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q2--
2024 Q1--
2023 Q3-10
2023 Q1--

LUCD Ownership FAQ


Who Owns Lucid Diagnostics?

Lucid Diagnostics shareholders are primarily institutional investors at 6.41%, followed by 60.83% insiders and 32.76% retail investors. The average institutional ownership in Lucid Diagnostics's industry, Medical Device Stocks, is 40.18%, which Lucid Diagnostics falls below.

Who owns the most shares of Lucid Diagnostics?

Lucid Diagnostics’s largest shareholders are Luminus management (1.02M shares, 2.02%), Vanguard group (560.92K shares, 1.11%), and Sargent investment group (541.5K shares, 1.07%). Together, they hold 4.21% of Lucid Diagnostics’s total shares outstanding.

Does Blackrock own Lucid Diagnostics?

Yes, BlackRock owns 0.06% of Lucid Diagnostics, totaling 27.31K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 22.39K$. In the last quarter, BlackRock decreased its holdings by -24.336K shares, a -47.12% change.

Who is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested?

Luminus management is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 1.02M Lucid Diagnostics shares, valued at 832.39K$.

Who is the top mutual fund holder of Lucid Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lucid Diagnostics shares, with 0.88% of its total shares outstanding invested in 612.6K Lucid Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools